Complete Filing Data
Ascendis Pharma A/S reported Cash And Cash Equivalents of $616.04 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Ascendis Pharma A/S did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling General And Administrative Expense | $457.9M | $291.1M | $264.4M | $221.2M | $160.2M | $76.7M | $48.5M | $25.1M | $13.5M | $11.5M | $9.4M |
| Research And Development Expense | $303.6M | $307.0M | $413.5M | $379.6M | $295.9M | $260.9M | $191.6M | $140.3M | $99.6M | $66.0M | $40.5M |
| Profit Loss From Operating Activities | -$136.3M | -$278.8M | -$455.5M | -$561.8M | -$451.8M | -$330.6M | -$226.7M | -$154.8M | -$111.5M | -$72.9M | -$41.8M |
| Profit Loss Before Tax | -$212.7M | -$373.2M | -$474.1M | -$577.8M | -$383.9M | -$419.2M | -$218.3M | -$130.5M | -$124.4M | -$68.7M | -$33.6M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax | -$3.5M | $1.1M | -$2.7M | -$327.0K | $3.9M | -$42.0K | -$37.0K | $17.0K | $65.0K | $6.0K | -$14.0K |
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | -$3.5M | $1.1M | -$2.7M | -$327.0K | $3.9M | -$42.0K | -$37.0K | $17.0K | $65.0K | $6.0K | -$14.0K |
| Income Tax Expense Continuing Operations | $15.4M | $4.8M | $7.3M | $5.4M | -$367.0K | -$219.0K | -$234.0K | -$394.0K | -$477.0K | -$227.0K | -$652.0K |
| Comprehensive Income Attributable To Owners Of Parent | -$231.6M | -$377.0M | -$484.2M | -$583.5M | -$379.7M | -$419.0M | -$218.1M | -$130.1M | -$123.8M | -$68.5M | -$32.9M |
| Comprehensive Income | -$231.6M | -$377.0M | -$484.2M | -$583.5M | -$379.7M | -$419.0M | -$218.1M | -$130.1M | -$123.8M | -$68.5M | -$32.9M |
| Profit Loss | -$228.0M | -$378.1M | -$481.4M | -$583.2M | -$383.6M | -$419.0M | -$218.0M | -$130.1M | -$123.9M | -$68.5M | -$32.9M |
| Share Of Profit Loss Of Associates Accounted For Using Equity Method | $16.3M | -$20.1M | -$18.4M | -$17.7M | $12.0M | -$9.5M | -$8.1M | -$321.0K | |||
| Profit Loss Attributable To Owners Of Parent | -$228.0M | -$378.1M | -$481.4M | -$583.2M | -$383.6M | -$419.0M | -$218.0M | -$130.1M | |||
| Income Taxes Paid Refund Classified As Operating Activities | $6.7M | $5.5M | $4.5M | $3.0K | -$152.0K | -$1.1M | $279.0K | -$332.0K | -$153.0K | -$558.0K | -$740.0K |
| Gross Profit | $625.2M | $319.4M | $222.3M | $39.0M | $4.3M | $7.0M | $13.4M | ||||
| Cost Of Sales | $94.9M | $44.3M | $44.4M | $12.1M | $3.5M | $0.00 | $0.00 | ||||
| Adjustments For Non Cash Consideration Regarding Revenue | $5.6M | $27.1M | $2.4M | $2.5M | $2.4M | $3.5M | $6.5M | $10.5M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $616.0M | $559.5M | $392.2M | $444.8M | $446.3M | $584.5M | $598.1M | $277.9M | $195.4M | $180.3M | $119.6M | $50.2M |
| Cash Flows From Used In Operations | $68.2M | -$299.9M | -$464.3M | -$494.7M | -$419.7M | -$272.5M | -$185.0M | -$143.0M | -$96.1M | -$60.9M | -$44.2M | |
| Cash Flows From Used In Operating Activities | $53.9M | -$306.2M | -$467.4M | -$495.7M | -$417.6M | -$271.5M | -$175.9M | -$138.8M | -$95.1M | -$60.2M | -$43.5M | |
| Cash Flows From Used In Investing Activities | -$8.5M | $6.9M | $286.5M | $61.7M | -$110.6M | -$291.2M | -$5.2M | -$2.6M | -$941.0K | -$672.0K | -$1.0M | |
| Cash Flows From Used In Financing Activities | $36.3M | $443.9M | $134.3M | $396.8M | $351.4M | $602.7M | $493.6M | $203.3M | $124.7M | $117.5M | $105.7M | |
| Adjustments For Increase Decrease In Trade And Other Payables | -$10.4M | $27.0M | $3.6M | $45.9M | $39.2M | $7.9M | $7.5M | $8.3M | $10.8M | $4.7M | $3.4M | |
| Property Plant And Equipment | $146.5M | $98.7M | $110.6M | $129.1M | $126.0M | $108.1M | $45.1M | $4.3M | $2.6M | $2.4M | ||
| Other Current Receivables | $14.6M | $9.4M | $19.1M | $12.8M | $20.1M | $7.0M | $4.6M | $1.8M | $1.4M | $640.0K | ||
| Noncurrent Assets | $193.6M | $118.6M | $122.9M | $166.3M | $279.0M | $239.7M | $65.6M | $26.1M | $6.3M | $6.1M | ||
| Liabilities | $1.47B | $1.29B | $971.3M | $826.4M | $201.3M | $141.1M | $79.6M | $38.9M | $23.8M | $13.5M | ||
| Equity And Liabilities | $1.30B | $1.18B | $825.6M | $1.09B | $1.08B | $979.8M | $676.7M | $319.0M | $211.0M | $190.1M | ||
| Distributable Equity | -$171.1M | -$113.9M | -$153.4M | $255.7M | $876.0M | $831.5M | $590.7M | $274.4M | $182.2M | $172.3M | ||
| Current Assets | $1.11B | $1.06B | $702.7M | $923.5M | $805.9M | $740.1M | $611.2M | $292.9M | $204.6M | $184.0M | ||
| Assets | $1.30B | $1.18B | $825.6M | $1.09B | $1.08B | $979.8M | $676.7M | $319.0M | $211.0M | $190.1M | ||
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $2.4M | $14.5M | $23.7M | $19.9M | $5.2M | $2.6M | $941.0K | $672.0K | $1.0M | |||
| Current Tax Liabilities | $6.4M | $1.2M | $2.3M | $5.5M | $198.0K | $301.0K | $119.0K | $9.0K | $0.00 | $286.0K | ||
| Current Liabilities | $1.07B | $907.9M | $736.5M | $716.8M | $100.4M | $52.8M | $48.0M | $38.9M | $23.8M | $13.5M | ||
| Current Trade Receivables | $141.3M | $166.3M | $35.9M | $11.9M | $2.2M | $387.0K | $804.0K | $6.0K | $188.0K | $287.0K | ||
| Trade And Other Current Payables To Trade Suppliers | $90.7M | $96.4M | $94.6M | $101.0M | $59.4M | $21.9M | $27.8M | $19.7M | $17.4M | |||
| Current Tax Assets Current | $1.8M | $1.8M | $802.0K | $883.0K | $893.0K | $0.00 | $1.5M | $849.0K | $778.0K | $740.0K | ||
| Investments In Associates | $32.5M | $13.6M | $5.7M | $22.9M | $38.3M | $9.2M | $15.5M | $17.1M | ||||
| Current Contract Liabilities | $4.9M | $936.0K | $1.2M | $0.00 | $2.6M | $363.0K | $858.0K | $6.9M | $0.00 | |||
| Noncurrent Liabilities | $396.0M | $377.3M | $234.8M | $109.6M | $100.9M | $88.3M | $31.6M | |||||
| Other Noncurrent Receivables | $10.9M | $2.3M | $2.1M | $1.9M | $1.8M | $1.4M | $1.5M | |||||
| Adjustments For Decrease Increase In Trade And Other Receivables | $15.6M | -$118.6M | -$32.8M | -$11.5M | -$6.7M | -$2.0M | -$2.2M | |||||
| Other Current Liabilities | $58.2M | $68.0M | $41.2M | $32.0M | $30.0M | $23.4M | $13.3M | |||||
| Noncurrent Contract Liabilities | $1.1M | $5.0M | $5.9M | $14.2M | $3.0M | $0.00 | ||||||
| Current Financial Assets Availableforsale | $7.3M | $290.7M | $235.8M | $134.3M | ||||||||
| Purchase Of Availableforsale Financial Assets | $0.00 | $213.8M | $226.0M | $537.8M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | $81.7M | $144.6M | -$46.6M | -$37.2M | -$176.8M | $39.9M | $312.5M | $61.8M | $28.7M | $56.6M | $61.2M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -$25.2M | $22.8M | -$6.0M | $35.7M | $38.6M | -$53.5M | $7.7M | $20.7M | -$13.7M | $4.1M | $8.2M |
| Proceeds From Issuing Shares | 0.00 | 309.9M | 0.00 | 0.00 | 367.9M | 580.5M | 480.3M | 216.4M | 133.1M | 126.0M | 114.1M |
| Proceeds From Exercise Of Warrants | $87.1M | $30.5M | $10.3M | $5.2M | $11.5M | $26.9M | $17.4M | ||||
| Payments Of Lease Liabilities Classified As Financing Activities | $10.4M | $6.4M | $6.4M | $4.8M | $4.0M | ||||||
| Payments For Share Issue Costs | $0.00 | $19.3M | $0.00 | $0.00 | $31.4M | $31.7M | $13.1M | $8.4M | $8.5M | $8.4M | |
| Proceeds From Disposal Or Maturity Of Availableforsale Financial Assets | $288.9M | $280.5M | $149.9M | $263.1M | |||||||
| Payments To Acquire Or Redeem Entitys Shares | 17.4M | 0.00 | 0.00 | 105.3M | 21.6M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Shares | 57.9M | 56.3M | 56.1M | 54.8M | 50.6M | 46.5M | 41.1M | 33.6M | 26.6M | 23.8M | |
| Basic And Diluted Earnings Loss Per Share | $-8.28 | $-4.69 | $-3.17 | $-3.68 | $-2.58 | ||||||
| Basic Earnings Loss Per Share | $-3.76 | $-6.53 | $-8.55 | $-10.40 | $-7.00 | $-3.68 | $-2.58 | $-1.39 | |||
| Diluted Earnings Loss Per Share | $-3.76 | $-6.53 | $-8.55 | $-10.40 | $-7.00 | $-3.68 | $-2.58 | $-1.39 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Finance Income | $114.0M | $25.6M | $43.9M | $52.2M | $59.7M | $1.8M | $17.8M | $24.7M | $923.0K | $7.3M | $11.0M |
| Finance Costs | $206.7M | $100.0M | $44.1M | $50.5M | $3.9M | $80.8M | $1.2M | $127.0K | $13.8M | $3.1M | $2.8M |
| Increase Decrease Through Sharebased Payment Transactions | $116.2M | $95.5M | $66.7M | $64.2M | $66.8M | $53.2M | $37.5M | $19.7M | $9.7M | $7.3M | $1.7M |
| Adjustments For Sharebased Payments | $116.2M | $95.5M | $66.7M | $64.2M | $66.8M | $53.2M | $37.5M | $19.7M | $9.7M | $7.3M | $1.7M |
| Adjustments For Depreciation Expense | $17.2M | $17.2M | $18.4M | $17.5M | $14.9M | $9.4M | $6.7M | $880.0K | $734.0K | $677.0K | $558.0K |
| Increase Decrease Through Transactions With Owners | $87.1M | $340.8M | $10.3M | $10.3M | $399.4M | $638.8M | $529.3M | $216.4M | $133.1M | $126.0M | $114.1M |
| Finance Income Received Classified As Operating Activities | $15.3M | $14.4M | $17.0M | $8.3M | $3.7M | $1.3M | $10.1M | $4.0M | $923.0K | $123.0K | $13.0K |
| Finance Costs Paid Classified As Operating Activities | $22.9M | $15.2M | $15.7M | $9.3M | $1.8M | $1.5M | $717.0K | $127.0K | $97.0K | $5.0K | $6.0K |
| Issued Capital | $8.3M | $8.1M | $7.7M | $7.7M | $7.6M | $7.2M | $6.4M | $5.7M | $5.0M | $4.4M | |
| Current Prepayments | $33.7M | $28.3M | $38.6M | $31.7M | $25.2M | $14.0M | $7.6M | $12.4M | $6.9M | $2.0M | |
| Costs Of Capital Increase Decrease | $19.3M | $20.0M | $31.4M | $31.7M | $13.1M | $8.4M | $8.5M | $8.4M | |||
| Adjustments For Decrease Increase In Prepaid Expenses | -$6.1M | $10.4M | -$11.4M | -$6.4M | -$11.2M | -$6.4M | $4.8M | ||||
| Adjustments For Amortisation Expense | $490.0K | $467.0K | $483.0K | $444.0K | $445.0K | ||||||
| Inventories | $301.5M | $295.6M | $208.9M | $130.7M | $75.4M | $0.00 | |||||
| Adjustments For Decrease Increase In Inventories | -$5.9M | -$86.7M | -$78.3M | -$55.3M | -$75.4M | ||||||
| Adjustments For Provisions | $77.6M | $62.0M | $26.2M | $6.1M | $1.2M | ||||||
| Adjustments For Increase Decrease In Prepayments | -$6.4M | $4.8M | -$5.5M | -$4.9M | $1.9M | -$3.2M | |||||
| Current Provisions | $166.4M | $99.1M | $32.7M | $7.3M | $1.2M | $0.00 | |||||
| Shortterm Borrowings | $429.4M | $458.2M | $407.1M | $399.2M | $7.0M | ||||||
| Longterm Borrowings | $385.3M | $365.1M | $223.0M | $95.4M | $98.0M | ||||||
| Longterm Deposits | $1.5M | $1.2M | $293.0K | $268.0K |
Most recent annual filing with the SEC: February 11, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.